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1. Introduction
The incidence of diabetes is increasing worldwide.
Saquib et al. (2012) reported that the number of diabetes
patients in Bangladesh has increased from 3.8% in 1995 to 9%
in 2010. The prevalence of diabetes is increasing in
Bangladesh due to inadequate healthcare facilities in rural
areas, lack of health consciousness, poor economic conditions,
lifestyle changes caused by rapid urbanization, and changes in
food habits. The Global Change Makers Program also
indicated that the poor people in Bangladesh are suffering
lifestyle-related diseases such as diabetes (Global Change
Makers Program, 2013).
Although the numbers of diabetic patients are rapidly
increasing, countermeasures have not been developed in
Bangladesh. There are several reasons for the difficulty in
coping with diabetes in Bangladesh, e.g., poverty, limitations
of health care facilities, low capability of spending on health
care expenses, lack of understanding of health condition, lack
of education, lack of information about diabetes, inadequate
opportunities for annual health checks and lack of knowledge
prevent people in this country from taking modern medicines.
Especially, facilities for diabetes treatment are not available in
health centers, and nurse practitioners do not have sufficient
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One of the best strategies in treatment of diabetes mellitus management involves control of
postprandial hyperglycemia through enzymatic inhibition of starch degradation. Emblica officinalis,
Terminalia bellirica, and Terminalia chebula are used as remedies in Ayurvedic medicine. In this
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glucosidase inhibitory potential activities in vitro. Methanol extract of T. chebula showed maximum
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?g/ml, compared with the standard drug, acarbose (IC50 value: 13 mg/ml). Rat intestinal sucrase
inhibitory activity was also investigated. The methanol extracts of these three plants at 1 mg/ml
showed considerable rat intestinal sucrase inhibitory activity. The hexane extract, ethyl acetate
extract, butanol extract, and water extract from the three plants were screened for yeast α -
glucosidase and rat intestinal sucrase inhibitory activity. Among the three plants, butanol extract
exhibited potent α-glucosidase inhibitory activity. Methanol and butanol extracts of the three plants
also showed excellent inhibitory activity against rat intestinal sucrase. E. officinalis, T. bellirica, and
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training for early identification of prediabetes in Bangladesh
(Islam et al., 2013).
Traditional medicines, which are commonly used in rural
areas, represent one solution to these problems. Traditional
medicine has a long history of use in Bangladesh, and has the
advantage of reduced medical expenses. Rahman (2013)
reported that large numbers of people use traditional
medicines for various diseases, such as skin diseases, joint
pain, diarrhea, cough, stomach problems, and diabetes.
Ayurvedic traditional medicine has been used since ancient
times in Bangladesh (Yoshida et al., 2016). Traditional
medicine has been reported to show fewer side effects than
allopathic medicines, and Vipula (2014) reported a good
response to Ayurvedic treatment compared to allopathic
treatment, with no side effects.
Traditional medicinal plants are also used to provide
affordable treatments for diabetes mellitus with advances in
many herbal medicinal health care systems in Bangladesh.
Various types of medicinal plants and plant parts are used in
traditional medicine for diabetes. In addition to traditional
practitioners reporting good responses, their treatments can be
validated scientifically based on the antidiabetic properties of
components of their medicinal plants. Grover et al. (2002)
showed that antihyperglycemic agents are present in various
plant extracts that have been used as traditional medicine.
In this study, we focused on three plants, Emblica
officinalis, Terminalia bellirica, and Terminalia chebula (Fig.
1), which are widely distributed southern India, Pakistan,
Bangladesh and other South-East Asian countries and have
been extensively used in traditional medicine in Bangladesh
and the Indian subcontinent. The traditional herbal
formulation consisting of a combination of fruits of these three
plants called “triphala” is very popular in traditional
Ayurvedic medicine, and has been used for thousands of years
against various types of disease. Mukherjee et al. (2006)
reported that “triphala and triphala mixture” follows a
standardized ayurvedic formula, which has been clinically
tested and shown to exhibit good results against constipation
and appetite problems.
These three plants are well known as individual herbal
remedies. E. officinalis has been reported to possess
antiinflammatory (Golechha et al., 2014), antioxidant
(Scartezzini et al., 2006), hepatoprotective (Jose et al., 2000),
antipyretic and analgesic activities (Perianayagam et al.,
2004). T. chebula has been reported to show anticancer (Ahuja
et al., 2013), antiviral (Kim et al., 2001), antibacterial (Kannan
et al., 2009), antioxidant (Cheng et al., 2003), and wound
healing activities (Singh et al., 2009). T. bellirica has been
studied for its antimicrobial (Devi et al., 2014), anti-HIV-1,
antimalarial, antifungal (Valsaraj et al., 1997), analgesic, and
antipyretic activities (Sharma et al., 2010).
Moreover, Sabu and Kuttan (2002) reported that oral
administration of an extract of E. officinalis, T. bellirica, and
T. chebula fruits effectively decreased the serum glucose level
in diabetic rats. T. chebula seed extracts showed a remarkable
decrease in blood glucose level by increasing insulin secretion
in both short and long term studies (Rao and Nammi, 2006).
The therapeutic potentials of various parts of the above
three plants from different regions have been evaluated in
previous studies. However, the antidiabetic potential of the
leaves collected from Bangladesh has not been reported.
While the fruits and seeds of E. officinalis, T. chebula, and T.
bellirica have been reported to show antihyperglycemic
effects, there have been no studies regarding the ? -
glucosidase inhibitory activity of leaves of these three plants
collected from Bangladesh. The present study was designed to
evaluate the antidiabetic potentials of different extracts of
these three plant leaves through monitoring of the inhibitory
effects on yeast and rat intestinal ?-glucosidase.
Alfa-glucosidases, which include maltase, maltase-
Inhibitory effects of Bangladeshi medicinal plant leaf extracts on ?-glucosidase activity
50
Fig.1. Plant leaves used in this study.
(A) E. officinalis belongs to the family Euphorbiaceae. (B) T. chebula belongs to the family Combretaceae.
(C) T. bellirica belongs to the family Combretaceae.
A. Emblica officinalis B.Terminalia chebula C. Terminilia bellirica
glucoamylase, etc., are the key enzymes. The ?-glucosidase
from the yeast, Saccharomyces cerevisiae is commonly used
to search for biologically active compounds with inhibitory
effects on the enzyme in vitro. Hogan et al. (2010) used yeast
?-glucosidase as a model for isolation and identification of
inhibitory substances from natural products. The p-
nitrophenyl-?-D-glucopyranoside was used as a synthetic
substrate in the assay of yeast?- glucosidase, which catalyzes
glucose and p-nitrophenol. Yeast ?-glucosidase and p-
nitrophenyl-?-D-glucopyranoside substrates were developed
for analysis of maltase inhibitory activity. Starch is the most
important carbohydrate in the human body, and is catalyzed
into maltose by ?-amylase, which in turn is catalyzed into
glucose by maltase in the brush-border surface membrane of
the small intestine.
Sucrose is the most commonly used sugar all over the
world, and is degraded into glucose and fructose by the ?-
glucosidase, sucrase. Rat intestinal acetone powder has been
used as a source of sucrase for in vitro assays with sucrose as
the substrate. Ohta et al. (2002) reported that the rat intestinal
acetone powder ?-glucosidase closely mimics that in the
mammalian system in vivo and may be a superior model for
use in studies to develop methods for the control of
postprandial blood glucose. Enzymes from different sources
catalyze different substrates. Therefore, we used two types of
?-glucosidase, i.e., yeast ?-glucosidase and rat intestinal ?-
glucosidase, in this study.
Diabetes mellitus is a group of serious metabolic
disorders associated with high blood glucose levels due to a
failure of the body to produce insulin properly. At present,
three main types of diabetes are known, i.e., type I insulin-
dependent diabetes, type II non-insulin-dependent diabetes,
and gestational diabetes (International Diabetes Federation,
2013). Type II has the highest prevalence rate, and the control
of postprandial blood glucose level is important in its
treatment. The inhibition of?-glucosidase is essential to delay
carbohydrate digestion and absorption, reduce blood glucose
levels, and finally control postprandial hyperglycemia.
Acarbose, miglitol, and voglibose are well- known clinically
approved inhibitors of ?-glucosidase activity (Van de Laar,
2008). However, these ?-glucosidase inhibitors have a
number of undesirable side effects, including gastrointestinal
problems (Cheng et al., 2005). Therefore, natural ?-
glucosidase inhibitors that are safe, effective, and have no or
only minor side effects are required.
2. Materials and Methods
2.1) Plant collection and extraction
The leaves of the three plant species were collected from
the Bangladesh Agricultural University, packed in the
newspaper, and dried in the sun. The dried samples were
crushed in a blender, and then boiled in methanol at 60? -
70? three times. Boiled leaf extracts were dried under
reduced pressure using a rotary evaporator. These dried
methanol extracts were dissolved in 30% hexane/70%
methanol solution and successively partitioned with the same
volume of hexane, ethyl acetate, butanol, and water by adding
each solution as shown in Fig. 2. The solvents were again
evaporated and the remaining substances were used as the test
materials. The methanol extracts and their partitioned fractions
were monitored for inhibitory effects on ?-glucosidase
activity.
Generally, plant bioactive compounds consist of various
classes of chemicals, such as alkaloids, glycosides, lignins,
tannins, terpenoids, etc. The methanol extracts of the plants
were used because many molecules, including fatty acids,
water-soluble materials, and other bioactive compounds, are
soluble in methanol. The major biological compound,
bartogenic acid, was identified from the methanol extract of
Barringtonia racemosa seed (Gowri et al., 2007). Therefore,
methanol is important in screening for biologically active
compounds, and was used in the present study.
2.2) Yeast α-glucosidase inhibitory assay
The inhibitory activity of yeast ?-glucosidase (Wako
Pure Chemical Industries, Ltd., Osaka, Japan) was determined
by the method of Babu et al. (2004) with slightly
modifications. Aliquots of 20?l of the test samples dissolved in
methanol at 10 mg/ml were serially diluted in 96-well
microtiter plates. The plant extracts diluted in10?l of phosphate
buffer 0. 1 mol/l (pH 6. 8) and 150?l (5 mmol/ml) of p-
nitrophenyl-?-D-glucopyranoside (PNPG) were added to
each well. The reaction was started by addition of 20?l (5
?g/ml) of the enzyme to the reaction mixture in the 96-well
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Fig.2. Separation by partition scheme with several solvents.
The upper layers ( ) are hexane, ethyl acetate, and
butanol. The lower layers ( ) are water.
plates. Individual blanks where the substrate was replaced
with 40?l of phosphate buffer were prepared to correct for
background absorbance. The controls contained 20?l of phosphate
buffer in place of the test sample, while the leaf extract was
replaced with acarbose in positive controls. All determinations
were performed in triplicate. The changes in absorbance at 405
nm (A405) were recorded at 1-minute intervals for 10 minutes,
and the percentage inhibition was estimated from the slope
using the following equation:
Inhibition % ? (1- slope of test sample/slope of control) ? 100.
The concentration that gave the half-maximal response
(IC50) was determined from the sample concentration vs.
percentage inhibition rate. ?-glucosidase inhibitory activity
was expressed as inhibition % and IC50 value, with a lower
IC50 value was indicating higher inhibitory activity.
2.3) Rat intestinal α-glucosidase (sucrase) inhibitory
assay
Rat intestinal ?-glucosidase inhibitory activity was
determined by a modification of the method of Babu et al.
(2004). Aliquots of 20?l of plant extract test samples dissolved
in methanol at 10 mg/ml were added to each well of 96-well
plates. Then, 150?l of 5 mg/ml saccharose was added to each
well. Rat intestinal acetone powder (Sigma-Aldrich, St. Louis,
MO) was added at 100 mg/ml to phosphate buffer 0.1 mol/l
(pH 6.8) and sonicated for 5 minutes. The suspension was
centrifuged at 2500 rpm for 5 minutes to remove particulate
matter, and the resulting supernatant was used as the enzyme
solution. The reaction was initiated by addition of 30?l of the
enzyme to the reaction mixture in 96-well plates. The reaction
mixture was incubated at 37?C for 30 minutes followed by 70
?C for 3 minutes on a heating block to stop the reaction. The
reaction mixture was cooled to room temperature for 10
minutes and aliquots of 20?l were transferred to another plate.
The reaction was started by addition of 150 ?l of reagent
(Glucose C2; Wako) and cooled to 25?C for 15 minutes.
Individual blanks where the substrate was replaced with 50?l
of phosphate buffer were prepared to correct for background
absorbance. The controls contained 20?l of phosphate buffer
in place of the test sample, while the leaf extract was replaced
with acarbose in positive controls. All determinations were
performed in triplicate. The changes in absorbance at 492 nm
(A492) were recorded at 1-minute. The percentage inhibition
was estimated using the following equation:
Inhibition % ? (1 - (absorbance of test sample-absorbance of
blank)/(absorbance of control-absorbance of blank)) ? 100.
2.4) Statistical analysis
The effects of crude methanol extracts (Fig. 3) and
fractionated extracts (Fig. 4) of the leaves from three
medicinal plants, E. officinalis, T. bellirica, and T. chebula
were examined by analysis of variance (ANOVA) followed by
Tukey’s multiple comparison tests using SPSS version 16.0
for windows (SPSS Inc., Chicago, IL). In all analyses, p ?
0.01 was taken to indicate statistical significance.
3. Results
E. officinalis yielded the highest percentage (18%) of
methanol extract from 50 g of plant material (Table 1, with T.
chebula and T. bellirica showing methanol extract yields of
15% and 12%, respectively (Table 1). The methanol extracts
Inhibitory effects of Bangladeshi medicinal plant leaf extracts on ?-glucosidase activity
52
Fig.3. Effects of methanol extracts of the leaves from three
medicinal plants on yeast α-glucosidase activity (12.5 μ g/ml).
The same letters above the bars in the graph indicate that the
mean did not differ significantly, while different letters
indicate significant variation at P ? 0. 01. The values are
expressed as means ? standard deviation, n ? 3.
Fig. 4. Inhibitory effects of fractionated extracts of the
leaves from three medicinal plants on yeast α-glucosidase
activity (10 μ g/ml).
The same letters above the bars in the graph indicate that the
mean did not differ significantly, while different letters
indicate significant variation at P ? 0. 01. The values are
expressed as means ? standard deviation, n ? 3.
were screened for their ?-glucosidase inhibitory activities.
The methanol extracts of the three plants showed significant in
vitro?-glucosidase inhibitory activity compared with acarbose
(13 mg/ml), with T. chebula showing the highest inhibitory
activity (IC50 ? 15?g/ml), followed by T. bellirica (IC50 ?
34?g/ml), and E. officinalis (IC50 ? 50?g/ml) (Table 2).
The hexane fraction of T. chebula leaves was inactive,
while the ethyl acetate, butanol, and water fractions showed?
-glucosidase inhibitory activity. The T. chebula butanol
fraction showed a strong inhibitory effect with an IC50 value
of 10?g/ml (Table 3). The hexane fraction of E. officinalis leaf
extract showed no inhibitory activity against ?-glucosidase.
The butanol and ethyl acetate fractions of E. officinalis
showed almost the same inhibitory activities, with IC50 values
of 18?g/ml and 19?g/ml, respectively (Table 3). The hexane
fraction of T. bellirica leaves was also less active than the
ethyl acetate, butanol, and water fractions, with IC50 values for
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Table 1. Efficiency of methanol extraction from the leaves of three Bangladeshi medicinal plants.
Percentage extract yield (w/w) was calculated as (dry extract weight/dry starting material weight) ? 100.
Table 2: Effects of methanol extracts from the leaves of
three medicinal plants against yeast α-glucosidase.
Acarbose was used as a positive control.
IC50: Concentration of the antagonist that inhibited the
enzyme reaction by 50%.
Table 3. Inhibitory effects of fractionated extracts of three medicinal plants on yeast α-glucosidase activity.
Acarbose was used as a positive inhibitory molecule.
IC50: Concentration of the antagonist that inhibited the enzyme reaction by 50%.
NA: No activity.
the butanol and ethyl acetate fractions of 12?g/ml and 18
?g/ml, respectively (Table 3).
The inhibitory activities of the methanol extracts (12.5
?g/ml) and fractionated extracts (10?g/ml) from the three
plants against yeast ?-glucosidase were analyzed and the
results are shown in Figures 3 and 4, respectively. There were
significant differences in the effects of the methanol extracts
between the plant species, with that of T. chebula showing the
maximum inhibitory effect (46%) followed by E. officinalis
(32%) and T. bellirica (30%) (Fig. 3). There were no
significant differences in the inhibitory effects of ethyl acetate
extracts among the three plant species (Fig. 4). The butanol
extracts of T. chebula and T. bellirica showed similar
inhibitory effects (50% and 46%, respectively), while E.
officinalis showed a weaker effect (32%) (Fig. 4). The water
extract of T. chebula showed the greatest inhibitory effect
(50%), with E. officinalis and T. bellirica are showing lower
inhibitory effects (21% and 23%, respectively) (Fig. 4).
In this study, the inhibitory effects of leaf extracts from
the three plant species against sucrase activity were
determined and compared with that of acarbose (91%,
Supplemental Data, Table 1). The methanol extracts of E.
officinalis, T. chebula, and T. bellirica leaves at 1 mg/ml in the
reaction mixtures showed significant inhibitory effects against
sucrase enzyme activity (Supplemental Data, Table 1), with
that of T. chebula showing the greatest effect (89%). We also
investigated the inhibitory effects of hexane, ethyl acetate,
butanol, and water extracts of the leaves from these plants
against sucrase activity. The butanol extract of E. officinalis
and water extract of E. officinalis were shown to inhibit the
enzyme activity by 58% and 50%, respectively (Supplemental
Data, Table 1). However, the hexane extract of E. officinalis
showed only a weak inhibitory effect (33%) on sucrase
activity, while acarbose as a positive control showed 91%
inhibition of the enzyme activity at a concentration of 1 mg/ml
(Supplemental Data, Table 1).
Ethyl acetate, butanol, and water fractions of T. chebula
leaves showed the highest sucrase inhibitory effects (54%,
67%, and 62%, respectively), and the weakest effect was
observed for the hexane extract of T. chebula (39%,
Supplemental Data, Table 1). The butanol extract of T.
bellirica leaves showed an inhibitory effect of 50%, while the
Inhibitory effects of Bangladeshi medicinal plant leaf extracts on ?-glucosidase activity
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Supplemental Data.
Table 1. Inhibitory effects of extracts of the leaves from three medicinal plants on rat intestinal sucrase and yeast α-
glucosidase.
The values are expressed as means ? standard deviation, n ? 3.
hexane, ethyl acetate, and water extracts showed lower
inhibitory activities of 27%, 41%, and 38%, respectively
(Supplemental Data, Table 1).
4. Discussion
Although acarbose is a well-known antidiabetic
medication, Oki et al. (1999) reported that acarbose did not
inhibit yeast?-glucosidase activity, while it showed inhibitory
effects on rat, rabbit, and pig small intestinal ?-glucosidase
activities. Kim et al. (2004) reported a similar result where
pine bark extracts showed strong inhibitory effects against
yeast ?-glucosidase, while the standard drug, acarbose,
showed no inhibitory effect on yeast ?-glucosidase activity.
These observations were compatible with those of the present
study, in which acarbose showed only a weak inhibitory effect
against yeast ?-glucosidase with an IC50 value of 13 mg/ml,
while the three plant extracts showed strong inhibitory effects
against the activity of this enzyme (Table 3). In this study,
acarbose had an IC50 value of 13mg/ml for yeast ?-
glucosidase at 5?g/ml in the reaction mixture, whereas Shai et
al. (2011) reported that acarbose had an IC50 value of 1.5
mg/ml for yeast ?-glucosidase at 0.5 mg/ml in the reaction
mixture. These results indicated that the different inhibitory
effect of acarbose on yeast ?-glucosidase, which may have
been due to the use of different concentration of the enzyme.
Shai et al. (2011) also mentioned that the different
concentrations of the enzyme are responsible for different IC50
value of acarbose.
The methanol and butanol extracts of the leaves from the
three plant species, E. officinalis, T. bellirica, and T. chebula,
showed stronger inhibitory effects against yeast ?-
glucosidase than rat intestinal sucrase (Supplemental Data,
table 1). At 200?g/ml, methanol and butanol extracts of T.
chebula inhibited yeast ?-glucosidase activity by 90% and
97%, respectively, while at 1 mg/ml, methanol and butanol
extracts of the effects of that inhibited on rat intestinal sucrase
were lower at 89% and 67%, respectively. This result was
supported by those of Shai et al. (2011), who found that
acetone extracts of different plants had stronger inhibitory
effects against yeast ?-glucosidase than mammalian ?-
glucosidase. Havsteen (1983) classified flavonoids into six
groups based on the variation of benzopyran and phenyl
groups and their ring and linkage sites, i.e., flavone, flavonol,
flavanone, isoflavone, flavan-3-ol, and anthocyanidin. Tadera
et al. (2006) reported that the inhibitory effects on yeast ?-
glucosidase and rat intestinal ?-glucosidase differed
according to the chemical structure of flavonoids based on the
presence of absence of the OH group at the C-3 position of the
flavone (quercetin ? luteolin; kaempferol ? apigenin),
hydroxyl substitution on the B ring (flavonol: myricetin ?
quercetin ? kaempferol; flavone: luteolin ? apigenin), linkage
of the B-3 position (isoflavone and flavone groups: genistein
? apigenin), and 1,2- and 3,4-double bonds and lack of 4-CO
of cyanidin, which is responsible for significant inhibition of
yeast ?-glucosidase. On the other hand, the anthocyanidin
group and isoflavone group were associated with weak
inhibition of rat intestinal ?-glucosidase activity.
In the present study, butanol extracts of T. chebula and T.
bellirica showed stronger inhibitory effects against yeast ?-
glucosidase activities with IC50 values of 10?g/ml and 12
?g/ml, respectively (Table 3), than against rat intestinal ?-
glucosidase (Supplemental Data, table 1). This result was
supported by the previous report of Tadera et al. (2006), who
also found that yeast?-glucosidase was strongly inhibited by
flavonoids with IC50 values ? 15?M, and that rat small intestinal
?-glucosidase was weakly inhibited by many flavonoids
and faintly by the isoflavone and anthocyanidin groups.
Sim et al. (2010) reported that the substrate specificity
is responsible for different reactions because the differences
of active site of enzyme between N-terminal maltase-
glucoamylase and N-terminal sucrase-isomaltase where
maltose could be hydrolyzed efficiently by both N-terminal
sucrase-isomaltase and N-terminal maltase-glucoamylase,
because N-terminal sucrase-isomaltase has a narrow ? 1
subsite which accommodates both its?-1,4 (maltose) and?-
1, 6 (isomaltose) substrates, but N-terminal maltase-
glucoamylase has a wide ? 1 subsite, which is specific for the
?-1,4 substrate. The present study results showed different
reactions against yeast ?-glucosidase and rat intestinal ?-
glucosidase using the different extract of three plant leaves,
these different reactions might be due to the substrate
specificity, which was demonstrated by Sim et al. (2010).
The methanol extracts of T. chebula, T. bellirica, and E.
officinalis had IC50 values for yeast ?-glucosidase of 15
?g/ml, 34?g/ml, and 50?g/ml, respectively (Table 2). On the
other hand, Prihantini et al. (2014) reported that the methanol
extract of Distylium racemosum showed a strong inhibitory
effect on yeast ?-glucosidase with an IC50 value of 22.6 ?
1.9?g/ml, followed by Acer mono Maxim and Elaeocarpus
sylvestris with IC50 values of 56.5 ? 0.9?g/ml and 74.4 ?
0.9?g/ml, respectively. These results indicated that the ?-
glucosidase inhibitory activity of methanol extract of T.
chebula was much stronger than that of D. racemosum, which
has been identified as a?-glucosidase inhibitor. Nampoothiri
et al. (2011) reported that T. bellirica fruit extract showed
stronger inhibitory activity against ?-glucosidase than E.
officinalis fruit extract (IC50 values 0.75?g/ml and 1.0?g/ml,
respectively). These results indicated higher inhibitory
activities than those seen in the present study, which may have
been due to the use of different parts of the plants (i.e., fruit vs.
leaf extracts, respectively). In addition, Oboh et al. (2014)
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reported that different parts of Persea americana (avocado
pear) plants showed different?-glucosidase inhibitory activities.
These results of the present study indicated that the
methanol extract of T. chebula leaves had the highest
inhibitory potency against rat intestinal sucrase inhibitory
activity (89%), followed by those of E. officinalis (81%) and
T. bellirica (70%) (Supplemental Data, table 1), while Sabu
and Kuttan (2002) reported that the methanol extract of T.
bellirica fruits showed maximum inhibitory activity (52.74%),
followed by those of T. chebula (50.98%) and E. officinalis
(29. 52%). These discrepancies may have been due to
differences in the experimental approach, because our
experiments were performed in vitro, whereas Sabu and
Kuttan (2002) performed in vivo experiments. In the present
study, ethyl acetate extract of T. chebula leaves showed 54%
inhibition (1 mg/ml) against rat intestinal sucrase, while Kim
et al. (2011) reported that a high dose of the ethyl acetate
portion of ethanolic extract of T. chebula fruit (500 mg/kg)
reduced the levels of blood glucose. This result showed good
agreement with those of the present study.
The results of the present study indicated that the
methanol and butanol extracts of T. chebula leaves and
butanol extracts of T. bellirica leaves showed maximum
inhibitory effects on yeast ?-glucosidase activity. Methanol
and butanol extracts of the leaves of the three plants, T.
chebula, T. bellirica, and E. officinalis, showed the strong
inhibitory effects on rat intestinal sucrase activity. Thus, the
leaves of these three plant species may contain
antihyperglycemic compounds. Further structural elucidation
and characterization are required to identify for identifying the
biologically active constituents of these extracts, and in vivo
studies are also necessary to confirm these observations.
5. Conclusions
The leaf extracts of three Bangladeshi medicinal plants T.
chebula, T. bellirica, and E. officinalis, showed significant
inhibitory effects against ?-glucosidase and sucrase
activities. Butanol and methanol extracts of T. chebula leaves
and butanol extract of T. bellirica leaves showed significant
inhibitory effects on carbohydrate digestive enzymes, which
may function in controlling postprandial glucose levels.
However, further studies are needed to determine their
potential efficacy in the treatment of diabetes.
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